Background Enhanced recovery after surgery (ERAS) pathways are now implemented
worldwide with strong evidence that adhesion to such protocol reduces medical …

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with a median survival
time of 10-12 months. Clinically, these poor outcomes are attributed to several factors …

1 ESGE recommends against diagnostic/therapeutic papillectomy when adenoma is not
proven. Strong recommendation, low quality evidence. 2 ESGE recommends endoscopic …

Malignant biliary obstruction is a challenging condition, requiring a multimodal approach for
both diagnosis and treatment. Pancreatic adenocarcinoma and cholangiocarcinoma are the …

Objectives The influence of preoperative biliary drainage (PBD) for obstructive jaundiced
patients before pancreaticoduodenectomy is debated in the past decades. The aim of this …

Pancreatic adenocarcinoma is currently one of the leading causes of cancer‐related
morbidity and mortality with dismal long term survival after diagnosis. Nearly 85% of …

Background The role of preoperative biliary drainage (PBD) on obstructive jaundice patients
is still controversial. The aim of this retrospective study is to clarify the effect of PBD on …

Aim The aim of this retrospective study is to develop and validate a predictive nomogram for
predicting the risk of post-operative abdominal infection (PAI) in patients undergoing …

Pancreatic cancer has traditionally been associated with a dismal prognosis, even in early
stages of the disease. In recent years, the introduction of newer generation chemotherapy …

Obstructive jaundice is a major symptom of pancreatic head cancer, and although its
amelioration is required before scheduling chemotherapy, the decision to perform biliary …